Agios Pharmaceuticals
AGIO
#5351
Rank
โ‚น141.09 B
Marketcap
โ‚น2,408
Share price
-3.89%
Change (1 day)
0.59%
Change (1 year)

Revenue for Agios Pharmaceuticals (AGIO)

Revenue in 2025 (TTM): โ‚น4.75 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น5.06 Billion. an increase over the revenue in the year 2024 that were of โ‚น3.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agios Pharmaceuticals from 2012 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น4.85 B54.9%
2024 โ‚น3.13 B40.22%
2023 โ‚น2.23 B89.5%
2022 โ‚น1.17 B
2021 N/A-100%
2020 โ‚น3.22 B-61.69%
2019 โ‚น8.40 B27.4%
2018 โ‚น6.59 B140.32%
2017 โ‚น2.74 B-42.18%
2016 โ‚น4.74 B20.89%
2015 โ‚น3.92 B-5.15%
2014 โ‚น4.14 B162.44%
2013 โ‚น1.57 B14.82%
2012 โ‚น1.37 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น5.868 T 115,726.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.112 T 120,539.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น4.104 T 80,918.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
โ‚น15.69 B 209.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น217.56 B 4,194.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น302.07 B 5,862.19%๐Ÿ‡บ๐Ÿ‡ธ USA